<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37543802</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>31</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>IL12B and IL17 genes polymorphisms associated with differential susceptibility to juvenile idiopathic arthritis and juvenile-onset systemic lupus erythematosus in Chinese children.</ArticleTitle><Pagination><StartPage>e34477</StartPage><MedlinePgn>e34477</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e34477</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000034477</ELocationID><Abstract><AbstractText>Genetic factors play a crucial role in the immune response of juvenile idiopathic arthritis (JIA) and juvenile-onset systemic lupus erythematosus (JSLE). This study aimed to investigate the association of IL12B (rs3212227, rs6887695) and IL17 (rs2275913, rs763780) gene polymorphisms with the susceptibility of JIA and JSLE in Chinese children. A total of 303 healthy controls and 304 patients including 160 JIA and 144 patients were analyzed, and the genetic polymorphisms were genotyped by using a Sequenom MassArray system. There was a significant association between the IL12B rs3212227 genotype and the increased risk of JSLE (P = .01). For rs6887695, the minor allele C was significantly associated with the increased risk of JIA (odds ratio = 1.48, 95% confidence interval [CI] = 1.12-1.95, P = .005). Moreover, rs6887695 genotype was significantly associated with both JIA and JSLE susceptibility (P &lt; .05). Besides, IL12B haplotype GC significantly associated with the increased risk of JIA (P = .016). However, no significant difference was found between the IL17 (rs2275913, rs763780) gene polymorphisms and JIA or JSLE susceptibility (P &gt; .05). And similar genotype distributions of IL12B and IL17 polymorphisms were found between the patients with nephritis and without nephritis in JSLE (P &gt; .05). Our results indicated that IL12B polymorphisms was associated with an increased risk for the development of JIA and JSLE in Chinese children, highlighting the involvement of inflammation in the pathogenesis of JIA and JSLE. Moreover, there was a risk haplotype in IL12B which could increase the risk of JIA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Menglan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Leiwen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wensheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoqin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shasha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jiamin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xinle</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4786-8048</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C500879">IL12B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053762">Interleukin-12 Subunit p40</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508717">IL17A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001171" MajorTopicYN="Y">Arthritis, Juvenile</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053762" MajorTopicYN="Y">Interleukin-12 Subunit p40</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009393" MajorTopicYN="N">Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="Y">Interleukin-17</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>6</Day><Hour>7</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>6</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37543802</ArticleId><ArticleId IdType="pmc">PMC10403002</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000034477</ArticleId><ArticleId IdType="pii">00005792-202308040-00045</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">21684384</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, Lythgoe H, Midgley A, et al. . Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274.</Citation><ArticleIdList><ArticleId IdType="pubmed">31678365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6:538&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">20683438</ArticleId></ArticleIdList></Reference><Reference><Citation>Malattia C, Martini A. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27:351&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">24238692</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo PC, Murphy G, Isenberg DA. Pathology of systemic lupus erythematosus: the challenges ahead. Methods Mol Biol. 2014;1134:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">24497350</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh AO, Prahalad S. Genetics of juvenile idiopathic arthritis. Rheum Dis Clin North Am. 2017;43:435&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28711144</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosetti F, de la Cruz A, Crisp&#xed;n JC. Gene-function studies in systemic lupus erythematosus. Curr Opin Rheumatol. 2019;31:185&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">30672908</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell. 1996;85:311&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8616887</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3:133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">12563297</ArticleId></ArticleIdList></Reference><Reference><Citation>Croxford AL, Kulig P, Becher B. IL-12-and IL-23 in health and disease. Cytokine Growth Factor Rev. 2014;25:415&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">25130295</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 2000;1:515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">11197695</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Gorycka A, Sowinska A, Stypi&#x144;ska B, et al. . IL-12B gene polymorphisms and IL-12 p70 serum levels among patients with rheumatoid arthritis. Scand J Immunol. 2017;85:147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">27896842</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hakeim EH, Abd Elhameed ZA, Nouby FH, et al. . Association of Interleukin-12B polymorphism and serum level of interleukin-12 in a Sample of Egyptian patients with rheumatoid arthritis. Egypt J Immunol. 2020;27:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">33180384</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolova I, Ivanova M, Vasilev G, et al. . Impact of il12b polymorphisms on genetic susceptibility and IL-12p40 and IL-23 serum levels in rheumatoid arthritis. Immunol Invest. 2020;49:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31161840</ArticleId></ArticleIdList></Reference><Reference><Citation>Miteva LD, Manolova IM, Ivanova MG, et al. . Functional genetic polymorphisms in interleukin-12B gene in association with systemic lupus erythematosus. Rheumatol Int. 2012;32:53&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20658240</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat RM, Mohamed SF, Bassyouni IH, et al. . Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72:146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Gorycka A, Sowinska A, Stypinska B, et al. . Genetic variants in IL-12B and IL-27 in the polish patients with systemic lupus erythematosus. Scand J Immunol. 2016;84:49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">27059274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova M, Manolova I, Miteva L, et al. . Genetic variations in the IL-12B gene in association with IL-23 and IL-12p40 serum levels in ankylosing spondylitis. Rheumatol Int. 2019;39:111&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30443744</ArticleId></ArticleIdList></Reference><Reference><Citation>Altinova AE, Engin D, Akbay E, et al. . Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients. J Endocrinol Invest. 2010;33:451&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20061784</ArticleId></ArticleIdList></Reference><Reference><Citation>Had&#x17e;ija MP, Korolija M, Jemin N, et al. . Polymorphisms in the IL-18 and IL-12B genes and their association with the clinical outcome in croatian patients with Type 1 diabetes. Gene. 2013;512:477&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">23137633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolls JK, Lind&#xe9;n A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">15485625</ArticleId></ArticleIdList></Reference><Reference><Citation>Louahchi S, Allam I, Berkani L, et al. . Association study of single nucleotide polymorphisms of IL23R and IL17 in rheumatoid arthritis in the Algerian population. Acta Reumatol Port. 2016;41:151&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27606475</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao M, Xu W, Yang H, et al. . Interleukin-17 Gene Polymorphism (Rs2275913 G/A, Rs763780 C/T) in rheumatoid arthritis: meta-analysis based on ethnicity. Immunol Invest. 2021;50:685&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">32605468</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga M, Lara-Armi FF, Neves JSF, et al. . Influence of IL10 (rs1800896) Polymorphism and TNF-&#x3b1;, IL-10, IL-17A, and IL-17F SERUM LEVELS in ankylosing spondylitis. Mediators Inflamm. 2021;12:653611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287882</ArticleId><ArticleId IdType="pubmed">34290697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieli&#x144;ska J, &#x15a;wierkot J, Kolossa K, et al. . Polymorphisms within genes coding for IL-17A and F and their receptor as clinical hallmarks in ankylosing spondylitis. Genes (Basel) 2021;2021:3125922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566063</ArticleId><ArticleId IdType="pubmed">34744511</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves JSF, Visentainer JEL, Reis DMS, et al. . IL17F: a possible risk marker for spondyloarthritis in HLA-B*27 negative Brazilian patients. J Pers Med. 2021;11:520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228173</ArticleId><ArticleId IdType="pubmed">34200121</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Yu P, Wang Y, et al. . Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population. Inflamm Res. 2013;62:743&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23652560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha HF, Tantawy EA, Youssef MA. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: a relation to disease activity and severity. Gene. 2019;702:107&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">30898714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristova M, Kamenarska Z, Dzhebir G, et al. . The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis. Rheumatol Int. 2021;41:2205&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">34554306</ArticleId></ArticleIdList></Reference><Reference><Citation>Petty RE, Southwood TR, Manners P, et al. . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">14760812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett JC, Fry B, Maller J, et al. . Haploview analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Li Z, Chen J, et al. . SHEsisPlus, a toolset for genetic studies on polyploid species. Sci Rep. 2016;6:24095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822172</ArticleId><ArticleId IdType="pubmed">27048905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu KJ, Zhu CY, Shi G, et al. . Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. J Int Med Res. 2013;33:1785&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">23297015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Xu M. Candidate polymorphisms and susceptibility to inflammatory bowel disease: a systematic review and meta-analysis. Gene. 2020;753:144814.</Citation><ArticleIdList><ArticleId IdType="pubmed">32464244</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Liu H, Wang Y, et al. . The polymorphisms of interleukin-12B gene and susceptibility to inflammatory bowel diseases: a meta-analysis and trial sequential analysis. Immunol Invest. 2021;50:987&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">33390082</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhang C, Wang JB, et al. . Relationship between the IL12B (rs3212227) gene polymorphism and susceptibility to multiple autoimmune diseases: a meta-analysis. Mod Rheumatol. 2016;26:749&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26915668</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, et al. . Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand J Immunol. 2010;72:134&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20618772</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes da SIIF, Angelo HD, Rushansky E, et al. . Interleukin (IL)-23 Receptor, IL-17A and IL-17F gene polymorphisms in brazilian patients with rheumatoid arthritis. Mol Biol Rep. 2017;65:537&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">28547498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisar H, Pasha U, Mirza MU, et al. . Impact of IL-17F 7488T/C functional polymorphism on progressive rheumatoid arthritis: novel insight from the molecular dynamic simulations. Immunol Invest. 2021;50:416&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">32543936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazlett J, Stamp LK, Merriman T, et al. . IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun. 2012;13:282&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22130325</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlik A, Kotrych D, Malinowski D, et al. . IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17:208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864924</ArticleId><ArticleId IdType="pubmed">27169372</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Zhou X, Xiong Y, et al. . Association between interleukin-17A/F single nucleotide polymorphisms and susceptibility to osteoarthritis in a Chinese population. Medicine (Baltim). 2019;98:e14944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6708862</ArticleId><ArticleId IdType="pubmed">30896662</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiotis R, Bartolome N, Sanchez A, et al. . Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis. PLoS One. 2012;7:e43428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3440408</ArticleId><ArticleId IdType="pubmed">22984424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamana A, Balsa A, Rueda B, et al. . The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis. PLoS One. 2012;7:e43661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3427144</ArticleId><ArticleId IdType="pubmed">22937072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>